Cronos Group Inc. (CRON)

USD 1.61

(-4.46%)

Long Term Debt Summary of Cronos Group Inc.

  • Cronos Group Inc.'s latest annual long term debt in 2023 was 1.55 Million USD , down -38.77% from previous year.
  • Cronos Group Inc.'s latest quarterly long term debt in 2024 Q2 was 1.06 Million USD , down 0.0% from previous quarter.
  • Cronos Group Inc. reported annual long term debt of 2.54 Million USD in 2022, down -64.12% from previous year.
  • Cronos Group Inc. reported annual long term debt of 7.09 Million USD in 2021, down -16.45% from previous year.
  • Cronos Group Inc. reported quarterly long term debt of 1.3 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • Cronos Group Inc. reported quarterly long term debt of 1.55 Million USD for 2023 Q4, down -11.12% from previous quarter.

Annual Long Term Debt Chart of Cronos Group Inc. (2023 - 2013)

Historical Annual Long Term Debt of Cronos Group Inc. (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 1.55 Million USD -38.77%
2022 2.54 Million USD -64.12%
2021 7.09 Million USD -16.45%
2020 8.49 Million USD 27.13%
2019 6.68 Million CAD 0.0%
2018 - CAD -100.0%
2017 4.26 Million CAD 0.0%
2016 - CAD -100.0%
2015 360.31 Thousand CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%

Peer Long Term Debt Comparison of Cronos Group Inc.

Name Long Term Debt Long Term Debt Difference
ANI Pharmaceuticals, Inc. 309.66 Million USD 99.497%
Aquestive Therapeutics, Inc. 91.07 Million USD 98.288%
Collegium Pharmaceutical, Inc. 489.96 Million USD 99.682%
Dynavax Technologies Corporation 252.41 Million USD 99.382%
Esperion Therapeutics, Inc. 501.54 Million USD 99.689%
Cosmos Health Inc. 3.03 Million USD 48.638%
Pacira BioSciences, Inc. 513.79 Million USD 99.697%
PainReform Ltd. 30 Thousand USD -5096.667%
Sunshine Biopharma, Inc. 539.03 Thousand USD -189.221%
Sunshine Biopharma, Inc. 539.03 Thousand USD -189.221%
SCYNEXIS, Inc. 12.15 Million USD 87.178%
Safety Shot Inc 304.9 Thousand USD -411.303%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD -1231.011%
Alpha Teknova, Inc. 13.25 Million USD 88.235%
Embecta Corp. 1.62 Billion USD 99.904%
Bright Green Corporation 201.78 Thousand USD -672.612%
Intra-Cellular Therapies, Inc. 13.32 Million USD 88.301%
Journey Medical Corporation 14.62 Million USD 89.338%
Procaps Group, S.A. 28.41 Million USD 94.512%
Theratechnologies Inc. 51.26 Million USD 96.959%
Harrow Health, Inc. 183.17 Million USD 99.149%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD -1691.954%
Biofrontera Inc. 804 Thousand USD -93.905%
DURECT Corporation 2.7 Million USD 42.302%
Supernus Pharmaceuticals, Inc. 33.19 Million USD 95.304%
OptiNose, Inc. 611 Thousand USD -155.155%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 99.687%
Kala Pharmaceuticals, Inc. 34.19 Million USD 95.44%
RedHill Biopharma Ltd. 455 Thousand USD -242.637%
Organogenesis Holdings Inc. 60.74 Million USD 97.434%
Guardion Health Sciences, Inc. - USD -Infinity%
Cumberland Pharmaceuticals Inc. 12.78 Million USD 87.805%
Radius Health, Inc. 339.66 Million USD 99.541%
Universe Pharmaceuticals INC - USD -Infinity%
ProPhase Labs, Inc. 10.25 Million USD 84.802%
Phibro Animal Health Corporation 458.28 Million USD 99.66%
Procaps Group S.A. 28.41 Million USD 94.512%
Alvotech 1.02 Billion USD 99.848%
TherapeuticsMD, Inc. 6.53 Million USD 76.133%
Viatris Inc. 16.18 Billion USD 99.99%
Rockwell Medical, Inc. 8.29 Million USD 81.201%
Aytu BioPharma, Inc. 10.87 Million USD 85.667%
SIGA Technologies, Inc. 335.99 Thousand USD -364.001%
Tilray Brands, Inc. 287.93 Million USD 99.459%
Lifecore Biomedical, Inc. 120.51 Million USD 98.706%
Shineco, Inc. 10.01 Million USD 84.437%
PetIQ, Inc. 437.82 Million USD 99.644%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 210 Thousand USD -642.381%
Neurocrine Biosciences, Inc. 258.3 Million USD 99.396%
Alimera Sciences, Inc. 64.48 Million USD 97.583%
Silver Spike Investment Corp. - USD -Infinity%
Assertio Holdings, Inc. 38.51 Million USD 95.952%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD -1054.054%
Petros Pharmaceuticals, Inc. 6.85 Million USD 77.265%
Clever Leaves Holdings Inc. 720 Thousand USD -116.528%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -6833.82%
Avadel Pharmaceuticals plc 32.75 Million USD 95.241%
Hempacco Co., Inc. 5.93 Million USD 73.714%
Talphera, Inc. - USD -Infinity%
Alvotech 1.02 Billion USD 99.848%
Eagle Pharmaceuticals, Inc. 56.21 Million USD 97.227%
Lantheus Holdings, Inc. 616.12 Million USD 99.747%
Currenc Group, Inc. 2.5 Million USD 37.813%
Kamada Ltd. 7.43 Million USD 79.04%
Indivior PLC 235.66 Million USD 99.338%
Evoke Pharma, Inc. 5 Million USD 68.82%
Flora Growth Corp. 942 Thousand USD -65.499%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -6833.82%
Evolus, Inc. 120.35 Million USD 98.705%
HUTCHMED (China) Limited 48.18 Million USD 96.765%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 99.735%
Akanda Corp. 2.49 Million USD 37.569%